| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |